Management of chronic suppurative otitis media

• 1 National Aboriginal Community Controlled Health Organisation, PO Box 927, Broome, WA 6725
• 3 NACCHO Research Subcommittee, National Aboriginal Community Controlled Health Organisation, Deakin, ACT
• 4 School of Public Health and Tropical Medicine, James Cook University, Townsville, QLD
• 5 Kimberley Aboriginal Medical Services Council, Broome, WA, and Associate Professor, School of Public Health and Tropical Medicine, James Cook University, Townsville, QLD.

---

• 1. Couzos S, Lea T, Mueller R, et al. Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial. Med J Aust 2003; 179: 185-190. <eMJA full text> <MJA full text>
• 2. Acuin J, Smith A, Mackenzie I. Interventions for chronic suppurative otitis media (Cochrane Review). CD000473. In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
• 3. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. E9 Statistical principles for clinical trials. Rockville, Md. 1998. Available at: www.fda.gov/cder/guidance/ICH_E9-fnl.PDF (accessed Dec 2003).
• 4. Prevention of hearing impairment from chronic otitis media. Report of a WHO/CIBA Foundation Workshop held at The CIBA Foundation, London, UK, 19–21 Nov 1996. Geneva: World Health Organization, 1998. (WHO/PDH/98.4). Available at: www.who.int/pbd/pdh/Docs/COM-Cover-sum.html (accessed Jan 2003).
• 5. Simpson KL, Markham A. Ofloxacin otic solution: a review of its use in the management of ear infections. Drugs 1999; 58: 509-531.
• 6. Suzuki K, Nishimura T, Baba S. Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan. Infect Chemother 2003; 9: 46-52.